Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of <i>TP53</i> mutational status
Ibrahim Aldoss(City of Hope), Ryotaro Nakamura(City Of Hope National Medical Center), Dennis D. Weisenburger(University of Nebraska Medical Center), Vinod Pullarkat(City of Hope), Sierra Min Li(City of Hope), Ahmed Aribi(City of Hope), Stephen J. Forman(City Of Hope National Medical Center), Ricardo Spielberger(City of Hope), Monzr M. Al Malki(City of Hope), Milhan Telatar(City of Hope), Joyce Murata‐Collins, Guido Marcucci(City of Hope), Victoria Bedell, Amandeep Salhotra(City of Hope), Haris Ali(City of Hope), Michelle Afkhami(City Of Hope National Medical Center), Patricia Aoun(University of Nebraska Medical Center), Raju Pillai(City Of Hope National Medical Center), Hao Hong(University of Michigan–Ann Arbor), David Senitzer(City of Hope), Samer K. Khaled, Ketevan Gendzekhadze(City Of Hope National Medical Center), Anh Tuan Pham(City of Hope), Thai M. Cao(City of Hope), Margaret O’Donnell(City Of Hope National Medical Center), David S. Snyder(City Of Hope National Medical Center), Joycelynne Palmer(City of Hope), Abbas Padeganeh, Anthony S. Stein(University of Hohenheim)
Cited by 37
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k